{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:17:59Z","timestamp":1776734279006,"version":"3.51.2"},"reference-count":156,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100002367","name":"Strategic Priority Research Program of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDA12040322"],"award-info":[{"award-number":["XDA12040322"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Institutes for Drug Discovery and Development, Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["CASIMM0120164019"],"award-info":[{"award-number":["CASIMM0120164019"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Pujiang Program","doi-asserted-by":"publisher","award":["16PJ1410700"],"award-info":[{"award-number":["16PJ1410700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2019,3,28]]},"abstract":"<jats:sec><jats:title\/><jats:p>Artemisinin is isolated from Artemisia annua L. with peroxide-containing sesquiterpene lactone structure. Because of its unique structural characteristics and promising anticancer, antivirus activities, it has recently received increasing attention. The aim of this review is to summarize recent discoveries of artemisinin&amp;#039;s novel derivatives with new pharmaceutical effects beyond malaria with a focus on its antitumor and antivirus activity, as well as potential results of combination therapy with other clinical drugs.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1568026619666190122144217","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T13:00:40Z","timestamp":1548334840000},"page":"205-222","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Biological Activities of Artemisinin Derivatives Beyond Malaria"],"prefix":"10.2174","volume":"19","author":[{"given":"Xiaoyan","family":"Liu","sequence":"first","affiliation":[{"name":"CAS Key Laboratory for Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguo","family":"Cao","sequence":"additional","affiliation":[{"name":"College of Life and Environmental Sciences, Shanghai Normal University, Shanghai, 201418, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guozheng","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Life and Environmental Sciences, Shanghai Normal University, Shanghai, 201418, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingjie","family":"Zhao","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory for Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingshan","family":"Shen","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory for Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2007.07.001","volume":"13","author":"Efferth T.","year":"2007","unstructured":"Efferth T, Li PCH, Konkimalla VSB, Kaina B. From traditional chinese medicine to rational cancer therapy.","journal-title":"Trends Mol Med"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jep.2015.10.010","volume":"176","author":"L\u00fc S.","year":"2015","unstructured":"L\u00fc S, Wang Q, Li G, Sun S, Guo Y, Kuang H. The treatment of rheumatoid arthritis using chinese medicinal plants: From pharmacology to potential molecular mechanisms.","journal-title":"J Ethnopharmacol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jep.2014.05.066","volume":"155","author":"Ding W.","year":"2014","unstructured":"Ding W, Gu J, Cao L, Li N, Ding G, Wang Z, Chen L, Xu X, Xiao W. Traditional chinese herbs as chemical resource library for drug discovery of anti-infective and anti-inflammatory.","journal-title":"J Ethnopharmacol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.canlet.2010.07.015","volume":"332","author":"Li-Weber M.","year":"2013","unstructured":"Li-Weber M. Targeting apoptosis pathways in cancer by chinese medicine.","journal-title":"Cancer Lett"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","volume":"1830","author":"Cragg G.M.","year":"2013","unstructured":"Cragg GM, Newman DJ. Natural products: A continuing source of novel drug leads.","journal-title":"Biochim Biophys Acta"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrd1657","volume":"4","author":"Koehn F.E.","year":"2005","unstructured":"Koehn FE, Carter GT. The evolving role of natural products in drug discovery.","journal-title":"Nat Rev Drug Discov"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1021\/np030096l","volume":"66","author":"Newman D.J.","year":"2003","unstructured":"Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981-2002.","journal-title":"J Nat Prod"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jep.2008.09.017","volume":"120","author":"de Ridder S.","year":"2008","unstructured":"de Ridder S, van der Kooy F, Verpoorte R. Artemisia annua as a self-reliant treatment for malaria in developing countrie","journal-title":"J Ethnopharmacol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.apjtm.2017.05.002","volume":"10","author":"Maroyi A.","year":"2017","unstructured":"Maroyi A. Traditional usage, phytochemistry and pharmacology of Hochst. ex C. Krauss.","journal-title":"Asian Pac J Trop Med"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00249-016-1141-2","volume":"46","author":"Peter B.","year":"2017","unstructured":"Peter B, Bosze S, Horvath R. Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials.","journal-title":"Eur Biophys J"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1007\/s00436-017-5647-z","volume":"116","author":"Phompradit P.","year":"2017","unstructured":"Phompradit P, Chaijaroenkul W, Na-Bangchang K. Cellular mechanisms of action and resistance of to artemisinin.","journal-title":"Parasitol Res"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1039\/C5NP00133A","volume":"32","author":"Kong L.Y.","year":"2015","unstructured":"Kong LY, Tan RX. Artemisinin, A miracle of traditional chinese medicine.","journal-title":"Nat Prod Rep"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/ptr.6077","volume":"32","author":"Li J.","year":"2018","unstructured":"Li J, Zhang C, Gong M, Wang M. Combination of artemisinin-based natural compounds from L. for the treatment of malaria: Pharmacodynamic and pharmacokinetic studies.","journal-title":"Phytother Res"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","volume":"2","author":"Krishna S.","year":"2014","unstructured":"Krishna S, Ganapathi S, Ster IC, Saeed MEM, Cowan M, Finlayson C, Kovacsevics H, Jansen H, Kremsner PG, Efferth T, Kumar D. A randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer.","journal-title":"EBioMedicine"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.phymed.2015.10.003","volume":"22","author":"Efferth T.","year":"2015","unstructured":"Efferth T, Zacchino S, Georgiev MI, Liu L, Wagner H, Panossian A. Nobel Prize for artemisinin brings phytotherapy into the spotlight.","journal-title":"Phytomedicine"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","volume":"228","author":"Klayman D.L.","year":"1985","unstructured":"Klayman DL. Qinghaosu (artemisinin): An antimalarial drug from china.","journal-title":"Science"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/IDR.S123887","volume":"11","author":"Zuber J.A.","year":"2018","unstructured":"Zuber JA, Takala-Harrison S. Multidrug-resistant malaria and the impact of mass drug administration.","journal-title":"Infect Drug Resist"},{"key":"ref=18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00288-18","volume":"62","author":"Oiknine-Djian E.","year":"2018","unstructured":"Oiknine-Djian E, Weisblum V, Panet A, Wong HN, Haynes RK, Wolf DG. The artemisinin derivative artemisone is a potent inhibitor of human cytomegalovirus replication.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40264-018-0659-x","volume":"41","author":"Ndagije H.B.","year":"2018","unstructured":"Ndagije HB, Nambasa V, Manirakiza L, Kusemererwa D, Kajungu D, Olsson S, Speybroeck N. The burden of adverse drug reactions due to artemisinin-based antimalarial treatment in selected ugandan health facilities: An active follow-up study.","journal-title":"Drug Safetyety"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ptr.5958","volume":"32","author":"Zyad A.","year":"2018","unstructured":"Zyad A, Tilaoui M, Jaafari A, Oukerrou MA, Mouse HA. More insights into the pharmacological effects of artemisinin.","journal-title":"Phytother Res"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40264-018-0659-x","volume":"41","author":"Ndagije H.B.","year":"2018","unstructured":"Ndagije HB, Nambasa V, Manirakiza L, Kusemererwa D, Kajungu D, Olsson S, Speybroeck N. The burden of adverse drug reactions due to artemisinin-based antimalarial treatment in selected ugandan health facilities: an active follow-up study.","journal-title":"Drug Safetyety"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00044-016-1778-5","volume":"26","author":"Dai Y.F.","year":"2017","unstructured":"Dai YF, Zhou WW, Meng J, Du XL, Sui YP, Dai L, Wang PQ, Huo HR, Sui F. The pharmacological activities and mechanisms of artemisinin and its derivatives: a systematic review.","journal-title":"Med Chem Res"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"9283","DOI":"10.1038\/s41598-017-08978-9","volume":"7","author":"de Boer J.G.","year":"2017","unstructured":"de Boer JG, Robinson A, Powers SJ, Burgers SLGE, Caulfield JC, Birkett MA, Smallegange RC, van Genderen PJJ, Bousema T, Sauerwein RW, Pickett JA, Takken W, Logan JG. Odours of -infected participants influence mosquito-host interactions.","journal-title":"Sci Rep"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11434-016-1105-z","volume":"61","author":"Yao W.B.","year":"2016","unstructured":"Yao WB, Wang F, Wang H. Immunomodulation of artemisinin and its derivatives.","journal-title":"Sci Bull (Beijing)"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.biotechadv.2018.01.001","volume":"36","author":"Efferth T.","year":"2018","unstructured":"Efferth T. Beyond malaria: The inhibition of viruses by artemisinin-type compounds.","journal-title":"Biotechnol Adv"},{"key":"ref=26","first-page":"5995","volume":"37","author":"Slezakova S.","year":"2017","unstructured":"Slezakova S, Ruda-Kucerova J. Ruda-Kucerova. Anticancer activity of artemisinin and its derivatives.","journal-title":"Anticancer Res"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/acsomega.7b00310","volume":"2","author":"Fr\u00f6hlich T.","year":"2017","unstructured":"Fr\u00f6hlich T, Reiter C, Ibrahim MM, Beutel J, Hutterer C, Zeittr\u00e4ger I, Bahsi H, Leidenberger M, Friedrich O, Kappes B, Efferth T, Marschall M, Tsogoeva SB. Synthesis of novel hybrids of quinazoline and artemisinin with high activities against plasmodium falciparum, human cytomegalovirus, and leukemia cells.","journal-title":"ACS Omega"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13659-018-0162-1","volume":"8","author":"Zhang Y.","year":"2018","unstructured":"Zhang Y, Xu G, Zhang S, Wang D, Saravana Prabha P, Zuo Z. Antitumor research on artemisinin and its bioactive derivatives.","journal-title":"Nat Prod Bioprospect"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"Siegel R.L.","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018.","journal-title":"CA Cancer J Clin"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11655-018-2910-1","volume":"24","author":"Zhao H.D.","year":"2018","unstructured":"Zhao HD, Xie HJ, Li J, Ren CP, Chen YX. Research progress on reversing multidrug resistance in tumors by using chinese medicine.","journal-title":"Chin J Integr Med"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.7150\/thno.22679","volume":"8","author":"Zhou L.","year":"2018","unstructured":"Zhou L, Wang H, Li Y. Stimuli-responsive nanomedicines for overcoming cancer multidrug resistance.","journal-title":"Theranostics"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"05","DOI":"10.1093\/annonc\/mdy047.043","volume":"29","author":"Zaher D.M.","year":"2018","unstructured":"Zaher DM, Omar HA. Energy restriction as a novel approach targeting breast cancer stem cells multi-drug resistance.","journal-title":"Ann Oncol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/nyas.13387","volume":"1401","author":"Yuan R.","year":"2017","unstructured":"Yuan R, Hou Y, Sun W, Yu J, Liu X, Niu Y, Lu JJ, Chen X. Natural products to prevent drug resistance in cancer chemotherapy: A review.","journal-title":"Ann N Y Acad Sci"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3892\/ol.2015.3183","volume":"10","author":"Zhang Z.S.","year":"2015","unstructured":"Zhang ZS, Wang J, Shen YB, Guo CC, Sai KE, Chen FR, Mei X, Han FU, Chen ZP. Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy.","journal-title":"Oncol Lett"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s11596-013-1212-x","volume":"33","author":"Deng X.R.","year":"2013","unstructured":"Deng XR, Liu ZX, Liu F, Pan L, Yu HP, Jiang JP, Zhang JJ, Liu L, Yu J. Holotransferrin enhances selective anticancer activity of artemisinin against human hepatocellular carcinoma cells.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2147\/OTT.S81041","volume":"8","author":"Zhang P.","year":"2015","unstructured":"Zhang P, Luo HS, Li M, Tan SY. Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2.","journal-title":"OncoTargets Ther"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/21691401.2016.1178131","volume":"45","author":"Jabbarzadegan M.","year":"2017","unstructured":"Jabbarzadegan M, Rajayi H, Mofazzal Jahromi MA, Yeganeh H, Yousefi M, Muhammad Hassan Z, Majidi J. Application of arteether-loaded polyurethane nanomicelles to induce immune response in breast cancer model.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1186\/s12885-017-3863-7","volume":"17","author":"Kumari K.","year":"2017","unstructured":"Kumari K, Keshari S, Sengupta D, Sabat SC, Mishra SK. Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment.","journal-title":"BMC Cancer"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bmcl.2013.11.032","volume":"24","author":"Buragohain P.","year":"2014","unstructured":"Buragohain P, Saikia B, Surineni N, Barua NC, Saxena AK, Suri N. Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bcp.2018.01.031","volume":"150","author":"Yan X.","year":"2018","unstructured":"Yan X, Li P, Zhan Y, Qi M, Liu J, An Z, Yang W, Xiao H, Wu H, Qi Y, Shao H. Dihydroartemisinin suppresses STAT3 signaling and Mcl-1 and Survivin expression to potentiate ABT-263-induced apoptosis in Non-small cell lung cancer cells harboring EGFR or RAS mutation.","journal-title":"Biochem Pharmacol"},{"key":"ref=41","first-page":"1949","volume":"15","author":"Wang D.","year":"2018","unstructured":"Wang D, Zhong B, Li Y, Liu X. Dihydroartemisinin increases apoptosis of colon cancer cells through targeting Janus kinase 2\/signal transducer and activator of transcription 3 signaling.","journal-title":"Oncol Lett"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13045-018-0561-0","volume":"11","author":"V\u00e5tsveen T.K.","year":"2018","unstructured":"V\u00e5tsveen TK, Myhre MR, Steen CB, W\u00e4lchli S, Lingj\u00e6rde OC, Bai B, Dillard P, Theodossiou TA, Holien T, Sundan A, Inderberg EM, Smeland EB, Myklebust JH, Oksvold MP. Artesunate shows potent anti-tumor activity in B-cell lymphoma.","journal-title":"J Hematol Oncol"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cam4.1276","volume":"7","author":"Cheng C.","year":"2018","unstructured":"Cheng C, Wang T, Song Z, Peng L, Gao M, Hermine O, Rousseaux S, Khochbin S, Mi JQ, Wang J. Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044.","journal-title":"Cancer Med"},{"key":"ref=44","first-page":"4083","volume":"14","author":"Zhao X.","year":"2017","unstructured":"Zhao X, Guo X, Yue W, Wang J, Yang J, Chen J. Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cells.","journal-title":"Exp Ther Med"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/molecules22081272","volume":"22","author":"Chen X.","year":"2017","unstructured":"Chen X, Wong YK, Lim TK, Lim WH, Lin QS, Wang JG, Hua ZC. Artesunate activates the intrinsic apoptosis of HCT116 cells through the suppression of fatty acid synthesis and the NF-kappa B pathway.","journal-title":"Molecules"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2016.07.033","volume":"381","author":"Lin R.","year":"2016","unstructured":"Lin R, Zhang Z, Chen L, Zhou Y, Zou P, Feng C, Wang L, Liang G. Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells.","journal-title":"Cancer Lett"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.3892\/mmr.2016.5073","volume":"13","author":"Jia J.","year":"2016","unstructured":"Jia J, Qin Y, Zhang L, Guo C, Wang Y, Yue X, Qian J. Artemisinin inhibits gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis.","journal-title":"Mol Med Rep"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1039\/c2mb05437j","volume":"8","author":"Eichhorn T.","year":"2012","unstructured":"Eichhorn T, Schloissnig S, Hahn B, Wendler A, Mertens R, Lehmann WD, Krauth-Siegel RL, Efferth T. Bioinformatic and experimental fishing for artemisinin-interacting proteins from human nasopharyngeal cancer cells.","journal-title":"Mol Biosyst"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejmech.2016.06.035","volume":"122","author":"Gaur R.","year":"2016","unstructured":"Gaur R, Pathania AS, Malik FA, Bhakuni RS, Verma RK. Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity.","journal-title":"Eur J Med Chem"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"e1466","DOI":"10.1038\/cddis.2014.434","volume":"5","author":"Button R.W.","year":"2014","unstructured":"Button RW, Lin F, Ercolano E, Vincent JH, Hu B, Hanemann CO, Luo S. Artesunate induces necrotic cell death in schwannoma cells.","journal-title":"Cell Death Dis"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.intimp.2013.09.015","volume":"17","author":"Zhou Z.H.","year":"2013","unstructured":"Zhou ZH, Chen FX, Xu WR, Qian H, Sun LQ, L\u00fc XT, Chen L, Zhang J, Ji HC, Fei SJ. Enhancement effect of dihydroartemisinin on human \u03b3\u03b4 T cell proliferation and killing pancreatic cancer cells.","journal-title":"Int Immunopharmacol"},{"key":"ref=52","first-page":"101","volume":"27","author":"Wu B.","year":"2012","unstructured":"Wu B, Hu K, Li S, Zhu J, Gu L, Shen H, Hambly BD, Bao S, Di W. Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer.","journal-title":"Oncol Rep"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.nano.2015.07.010","volume":"11","author":"Dwivedi A.","year":"2015","unstructured":"Dwivedi A, Mazumder A, du Plessis L, du Preez JL, Haynes RK, du Plessis J. anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells.","journal-title":"Nanomedicine (Lond)"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"18260","DOI":"10.18632\/oncotarget.15353","volume":"8","author":"Zhou Y.","year":"2017","unstructured":"Zhou Y, Wang X, Zhang J, He A, Wang YL, Han K, Su Y, Yin J, Lv X, Hu H. Artesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184.","journal-title":"Oncotarget"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.phymed.2015.11.001","volume":"22","author":"Michaelsen F.W.","year":"2015","unstructured":"Michaelsen FW, Saeed MEM, Schwarzkopf J, Efferth T. Activity of and artemisinin derivatives, in prostate carcinoma.","journal-title":"Phytomedicine"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ajps.2016.06.002","volume":"11","author":"Pawar J.N.","year":"2016","unstructured":"Pawar JN, Desai HR, Moravkar KK, Khanna DK, Amin PD. Exploring the potential of porous silicas as a carrier system for dissolution rate enhancement of artemether.","journal-title":"Asian J Pharm Sci"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/AAC.00596-17","volume":"62","author":"Gargano N.","year":"2018","unstructured":"Gargano N, Madrid L, Valentini G, D\u2019Alessandro U, Halidou T, Sirima S, Tshefu A, Mtoro A, Gesase S. The Eurartesim Dispersible Study Group Bassat, Q. Efficacy and tolerability outcomes of a phase II, randomized, open-label, multicenter study of a new water-dispersible pediatric formulation of dihydroartemisinin-piperaquine for the treatment of uncomplicated plasmodium falciparum malaria in african infants.","journal-title":"Antimicrob Agents Ch"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4269\/ajtmh.16-0731","volume":"97","author":"Supan C.","year":"2017","unstructured":"Supan C, Mombo-Ngoma G, Kombila M, Ospina Salazar CL, Held J, Lell B, Cantalloube C, Djeriou E, Ogutu B, Waitumbi J, Otsula N, Apollo D, Polhemus ME, Kremsner PG, Walsh DS. Phase 2a, open-label, 4-escalating-dose, randomized multicenter study evaluating the safety and activity of ferroquine (SSR97193) plus artesunate, versus amodiaquine plus artesunate, in african adult men with uncomplicated plasmodium falciparum malaria.","journal-title":"Am J Trop Med Hyg"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00280-018-3533-8","volume":"81","author":"Deeken J.F.","year":"2018","unstructured":"Deeken JF, Wang H, Hartley M, Cheema AK, Smaglo B, Hwang JJ, He AR, Weiner LM, Marshall JL, Giaccone G, Liu S, Luecht J, Spiegel JY, Pishvaian MJ. A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00280-016-2960-7","volume":"77","author":"K\u00f6nig M.","year":"2016","unstructured":"K\u00f6nig M, von Hagens C, Hoth S, Baumann I, Walter-Sack I, Edler L, Sertel S. Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: New audiological results from a prospective, open, uncontrolled, monocentric phase I study.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.etap.2017.12.004","volume":"57","author":"Li X.","year":"2018","unstructured":"Li X, Gu S, Sun D, Dai H, Chen H, Zhang Z. The selectivity of artemisinin-based drugs on human lung normal and cancer cells.","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00280-017-3251-7","volume":"79","author":"Bhaw-Luximon A.","year":"2017","unstructured":"Bhaw-Luximon A, Jhurry D. Artemisinin and its derivatives in cancer therapy: Status of progress, mechanism of action, and future perspectives.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","volume":"31","author":"Lai H.C.","year":"2013","unstructured":"Lai HC, Singh NP, Sasaki T. Development of artemisinin compounds for cancer treatmen","journal-title":"Invest New Drugs"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"e82962","DOI":"10.1371\/journal.pone.0082962","volume":"8","author":"Hooft van Huijsduijnen R.","year":"2013","unstructured":"Hooft van Huijsduijnen R, Guy RK, Chibale K, Haynes RK, Peitz I, Kelter G, Phillips MA, Vennerstrom JL, Yuthavong Y, Wells TNC. Anticancer properties of distinct antimalarial drug classes.","journal-title":"PLoS One"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/CAD.0000000000000547","volume":"28","author":"Steely A.M.","year":"2017","unstructured":"Steely AM, Willoughby JA, Sundar SN, Aivaliotis VI, Firestone GL. Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.","journal-title":"Anticancer Drugs"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00280-003-0751-4","volume":"53","author":"Chen H.H.","year":"2004","unstructured":"Chen HH, Zhou HJ, Wang WQ, Wu GD. Antimalarial dihydroartemisinin also inhibits angiogenesis.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.biopha.2013.01.013","volume":"67","author":"Du X.X.","year":"2013","unstructured":"Du XX, Li YJ, Wu CL, Zhou JH, Han Y, Sui H, Wei XL, Liu L, Huang P, Yuan HH, Zhang TT, Zhang WJ, Xie R, Lang XH, Jia DX, Bai YX. Initiation of apoptosis, cell cycle arrest and autophagy of esophageal cancer cells by dihydroartemisinin.","journal-title":"Biomed Pharmacother"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1159\/000358716","volume":"33","author":"Li Y.J.","year":"2014","unstructured":"Li YJ, Zhou JH, Du XX, Jia X, Wu CL, Huang P, Han Y, Sui H, Wei XL, Liu L, Yuan HH, Zhang TT, Zhang WJ, Xie R, Lang XH, Liu T, Jiang CL, Wang LY, Bai YX. Dihydroartemisinin accentuates the anti-tumor effects of photodynamic therapy inactivation of NF-\u03baB in Eca109 and Ec9706 esophageal cancer cells.","journal-title":"Cell Physiol Biochem"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2010.01.001","volume":"293","author":"Wang S.J.","year":"2010","unstructured":"Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, Xue DB, Bai XW, Sun B. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both and","journal-title":"Cancer Lett"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2016.05.033","volume":"157","author":"Xu G.","year":"2016","unstructured":"Xu G, Zou WQ, Du SJ, Wu MJ, Xiang TX, Luo ZG. Mechanism of dihydroartemisinin-induced apoptosis in prostate cancer PC3 cells: An iTRAQ-based proteomic analysis.","journal-title":"Life Sci"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4161\/cbt.27223","volume":"15","author":"Hu C.J.","year":"2014","unstructured":"Hu CJ, Zhou L, Cai Y. Dihydroartemisinin induces apoptosis of cervical cancer cells upregulation of RKIP and downregulation of bcl-2.","journal-title":"Cancer Biol Ther"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bcp.2012.02.002","volume":"83","author":"Zhang C.Z.","year":"2012","unstructured":"Zhang CZ, Zhang H, Yun J, Chen GG, Lai PBS. Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma and","journal-title":"Biochem Pharmacol"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2174\/1568026616666160212122820","volume":"16","author":"Ilamathi M.","year":"2016","unstructured":"Ilamathi M, Santhosh S, Sivaramakrishnan V. Artesunate as an anti-cancer agent targets stat-3 and Suppresses epatocellular carcinoma.","journal-title":"Curr Top Med Chem"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.phrs.2017.01.014","volume":"119","author":"Que Z.","year":"2017","unstructured":"Que Z, Wang P, Hu Y, Xue Y, Liu X, Qu C, Ma J, Liu Y. Dihydroartemisin inhibits glioma invasiveness a ROS to P53 to \u03b2-catenin signaling.","journal-title":"Pharmacol Res"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/med.21446","volume":"37","author":"Wong Y.K.","year":"2017","unstructured":"Wong YK, Xu C, Kalesh KA, He Y, Lin Q, Wong WSF, Shen HM, Wang J. Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action.","journal-title":"Med Res Rev"},{"key":"ref=76","first-page":"8759745","volume":"2018","author":"Jiang C.","year":"2018","unstructured":"Jiang C, Li S, Li Y, Bai Y. Anticancer effects of dihydroartemisinin on human esophageal cancer cells","journal-title":"Anal Cell Pathol (Amst)"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.phytochem.2017.11.010","volume":"146","author":"Schepetkin I.A.","year":"2018","unstructured":"Schepetkin IA, Kirpotina LN, Mitchell PT, Kishkentaeva AS, Shaimerdenova ZR, Atazhanova GA, Adekenov SM, Quinn MT. The natural sesquiterpene lactones arglabin, grosheimin, agracin, parthenolide, and estafiatin inhibit T cell receptor (TCR) activation.","journal-title":"Phytochemistry"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2174\/0929867323666160510123255","volume":"23","author":"Ren Y.","year":"2016","unstructured":"Ren Y, Yu J, Kinghorn AD. Development of anticancer agents from plant-derived sesquiterpene lactones.","journal-title":"Curr Med Chem"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/cbdd.13016","volume":"90","author":"Sun Q.","year":"2017","unstructured":"Sun Q, Wang J, Li Y, Zhuang J, Zhang Q, Sun X, Sun D. Synthesis and evaluation of cytotoxic activities of artemisinin derivatives.","journal-title":"Chem Biol Drug Des"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ejmech.2016.08.015","volume":"123","author":"Xu C.C.","year":"2016","unstructured":"Xu CC, Wu JJ, Xu T, Yao CH, Yu BY, Liu JH. Synthesis and cytotoxicity of novel artemisinin derivatives containing sulfur atoms.","journal-title":"Eur J Med Chem"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.3390\/molecules18032864","volume":"18","author":"Liu Y.","year":"2013","unstructured":"Liu Y, Liu Z, Shi J, Chen H, Mi B, Li P, Gong P. Synthesis and cytotoxicity of novel 10-substituted dihydroartemisinin derivatives containing N-arylphenyl-ethenesulfonamide groups.","journal-title":"Molecules"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bioorg.2016.03.008","volume":"66","author":"Ha V.T.","year":"2016","unstructured":"Ha VT, Kien VT, Binh H, Tien VD, My NTT, Nam NH, Baltas M, Hahn H, Han BW, Thao T, Vu TK. Design, synthesis and biological evaluation of novel hydroxamic acids bearing artemisinin skeleton.","journal-title":"Bioorg Chem"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s00044-016-1524-z","volume":"25","author":"Binh L.H.","year":"2016","unstructured":"Binh LH, Van NTT, Kien VT, My NTT, Chinh LV, Nga NT, Tien HX, Thao DT, Vu TK. Synthesis and cytotoxic evaluation of new triazole derivatives based on artemisinin via click chemistry.","journal-title":"Med Chem Res"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1016\/j.bmc.2017.04.041","volume":"25","author":"Jana S.","year":"2017","unstructured":"Jana S, Iram S, Thomas J, Liekens S, Dehaen W. Synthesis and anticancer activity of novel aza-artemisinin derivatives.","journal-title":"Bioorg Med Chem"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejmech.2015.08.035","volume":"103","author":"Liu G.","year":"2015","unstructured":"Liu G, Song S, Shu S, Miao Z, Zhang A, Ding C. Novel spirobicyclic artemisinin analogues (artemalogues): Synthesis and antitumor activities.","journal-title":"Eur J Med Chem"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/17460441.2016.1135125","volume":"11","author":"B\u00e9rub\u00e9 G.","year":"2016","unstructured":"B\u00e9rub\u00e9 G. An overview of molecular hybrids in drug discovery.","journal-title":"Expert Opin Drug Discov"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1574892809666140520150459","volume":"9","author":"Nepali K.","year":"2014","unstructured":"Nepali K, Sharma S, Kumar D, Budhiraja A, Dhar KL. Anticancer hybrids--A patent survey.","journal-title":"Recent Patents Anticancer Drug Discov"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2174\/1568026616666160927150839","volume":"17","author":"Sunil D.","year":"2017","unstructured":"Sunil D, Kamath PR. Multi-target directed indole based hybrid molecules in cancer therapy: An up-to-date evidence-based review.","journal-title":"Curr Top Med Chem"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2174\/1568026616666160927155515","volume":"17","author":"Kucuksayan E.","year":"2017","unstructured":"Kucuksayan E, Ozben T. Hybrid compounds as multitarget directed anticancer agents.","journal-title":"Curr Top Med Chem"},{"key":"ref=90","first-page":"4729","volume":"24","author":"Kumar B.","year":"2017","unstructured":"Kumar B, Singh S, Skvortsova I, Kumar V. Promising targets in anti-cancer drug development: Recent update","journal-title":"Curr Med Chem"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/cmdc.201600594","volume":"12","author":"Fr\u00f6hlich T.","year":"2017","unstructured":"Fr\u00f6hlich T, Ndreshkjana B, Muenzner JK, Reiter C, Hofmeister E, Mederer S, Fatfat M, El-Baba C, Gali-Muhtasib H, Schneider-Stock R, Tsogoeva SB. Synthesis of novel hybrids of thymoquinone and artemisinin with high activity and selectivity against colon cancer.","journal-title":"ChemMedChem"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/acsmedchemlett.7b00412","volume":"9","author":"Fr\u00f6hlich T.","year":"2017","unstructured":"Fr\u00f6hlich T, Reiter C, Saeed MEM, Hutterer C, Hahn F, Leidenberger M, Friedrich O, Kappes B, Marschall M, Efferth T, Tsogoeva SB. Synthesis of thymoquinone-artemisinin hybrids: new potent antileukemia, antiviral, and antimalarial agents.","journal-title":"ACS Med Chem Lett"},{"key":"ref=93","first-page":"639","volume":"2","author":"Bakry R.","year":"2007","unstructured":"Bakry R, Vallant RM, Najam-ul-Haq M, Rainer M, Szabo Z, Huck CW, Bonn GK. Medicinal applications of fullerenes.","journal-title":"Int J Nanomedicine"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebiom.2016.11.026","volume":"14","author":"Li X.","year":"2016","unstructured":"Li X, Zhou Y, Liu Y, Zhang X, Chen T, Chen K, Ba Q, Li J, Liu H, Wang H. Preclinical efficacy and safety assessment of artemisinin-chemotherapeutic agent conjugates for ovarian cancer.","journal-title":"EBioMedicine"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2014.01.043","volume":"75","author":"Reiter C.","year":"2014","unstructured":"Reiter C, Capc\u0131 Karag\u00f6z A, Fr\u00f6hlich T, Klein V, Zeino M, Viertel K, Held J, Mordm\u00fcller B, Emirda\u011f \u00d6zt\u00fcrk S, An\u0131l H, Efferth T, Tsogoeva SB. Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells.","journal-title":"Eur J Med Chem"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","volume":"97","author":"Reiter C.","year":"2015","unstructured":"Reiter C, Fr\u00f6hlich T, Zeino M, Marschall M, Bahsi H, Leidenberger M, Friedrich O, Kappes B, Hampel F, Efferth T, Tsogoeva SB. New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and : 2nd generation 1,2,4-trioxane-ferrocene hybrids.","journal-title":"Eur J Med Chem"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.2012.44.7888","volume":"31","author":"Trunzer K.","year":"2013","unstructured":"Trunzer K, Pavlick AC, Schuchter L, Gonzalez R, McArthur GA, Hutson TE, Moschos SJ, Flaherty KT, Kim KB, Weber JS, Hersey P, Long GV, Lawrence D, Ott PA, Amaravadi RK, Lewis KD, Puzanov I, Lo RS, Koehler A, Kockx M, Spleiss O, Schell-Steven A, Gilbert HN, Cockey L, Bollag G, Lee RJ, Joe AK, Sosman JA, Ribas A. Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma.","journal-title":"J Clin Oncol"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1158\/2159-8290.CD-12-0012","volume":"2","author":"Garraway L.A.","year":"2012","unstructured":"Garraway LA, J\u00e4nne PA. Circumventing cancer drug resistance in the era of personalized medicine.","journal-title":"Cancer Discov"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/138161209787315576","volume":"15","author":"Chow L.M.C.","year":"2009","unstructured":"Chow LMC, Chan TH. Novel classes of dimer antitumour drug candidates.","journal-title":"Curr Pharm Des"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1021\/acs.jmedchem.5b01380","volume":"59","author":"Fr\u00f6hlich T.","year":"2016","unstructured":"Fr\u00f6hlich T, \u00c7apc\u0131 Karag\u00f6z A, Reiter C, Tsogoeva SB. Artemisinin-derived dimers: Potent antimalarial and anticancer agents.","journal-title":"J Med Chem"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1021\/jm020119d","volume":"46","author":"Jung M.","year":"2003","unstructured":"Jung M, Lee S, Ham J, Lee K, Kim H, Kim SK. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer.","journal-title":"J Med Chem"},{"key":"ref=102","author":"Li Y.","year":"2011","unstructured":"Li Y, Zhu Y, Zhang Y, Zhou J, Cao L, Xie S.","journal-title":"Faming Zhuanli Shenqing"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ejps.2012.09.019","volume":"47","author":"Lombard M.C.","year":"2012","unstructured":"Lombard MC, N\u2019Da DD, Breytenbach JC, Kolesnikova NI, Tran Van Ba C, Wein S, Norman J, Denti P, Vial H, Wiesner L. Antimalarial and anticancer activities of artemisinin-quinoline hybrid-dimers and pharmacokinetic properties in mice.","journal-title":"Eur J Pharm Sci"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ardp.201000363","volume":"344","author":"Xie L.","year":"2011","unstructured":"Xie L, Zhao Y, Zhai X, Li P, Liu C, Li Y, Gong P. The application of tandem aza-wittig reaction to synthesize artemisinin-guanidine hybrids and their anti-tumor activity.","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bmc.2008.11.050","volume":"17","author":"Galal A.M.","year":"2009","unstructured":"Galal AM, Gul W, Slade D, Ross SA, Feng S, Hollingshead MG, Alley MC, Kaur G, ElSohly MA. Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity.","journal-title":"Bioorg Med Chem"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.bmc.2015.07.048","volume":"23","author":"Reiter C.","year":"2015","unstructured":"Reiter C, Fr\u00f6hlich T, Gruber L, Hutterer C, Marschall M, Voigtl\u00e4nder C, Friedrich O, Kappes B, Efferth T, Tsogoeva SB. Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities.","journal-title":"Bioorg Med Chem"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1570180813666160810155354","volume":"14","author":"Kien V.T.","year":"2017","unstructured":"Kien VT, Binh LH, Phong PH, Hien DT, My NTT, Nam NH, Thao DT, Baltas M, Vu TK. Novel artemisinin-derived dimers: Synthesis and evaluation of anticancer activities.","journal-title":"Lett Drug Des Discov"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ejmech.2018.03.010","volume":"150","author":"Zhang N.","year":"2018","unstructured":"Zhang N, Yu Z, Yang X, Hu P, He Y. Synthesis of novel ring-contracted artemisinin dimers with potent anticancer activities.","journal-title":"Eur J Med Chem"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1016\/j.bmc.2017.05.018","volume":"25","author":"Magoulas G.E.","year":"2017","unstructured":"Magoulas GE, Tsigkou T, Skondra L, Lamprou M, Tsoukala P, Kokkinogouli V, Pantazaka E, Papaioannou D, Athanassopoulos CM, Papadimitriou E. Synthesis of n\u03bfvel artemisinin dimers with polyamine linkers and evaluation of their potential as anticancer agents.","journal-title":"Bioorg Med Chem"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"e00747","DOI":"10.7554\/eLife.00747","volume":"2","author":"Bozic I.","year":"2013","unstructured":"Bozic I, Reiter JG, Allen B, Antal T, Chatterjee K, Shah P, Moon YS, Yaqubie A, Kelly N, Le DT, Lipson EJ, Chapman PB, Diaz LA, Vogelstein B, Nowak MA. Evolutionary dynamics of cancer in response to targeted combination therapy.","journal-title":"eLife"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(10)70079-7","volume":"10","author":"Douglas N.M.","year":"2010","unstructured":"Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN. Artemisinin combination therapy for vivax malaria.","journal-title":"Lancet Infect Dis"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00216-008-2527-5","volume":"393","author":"He S.P.","year":"2009","unstructured":"He SP, Tan GY, Li G, Tan WM, Nan TG, Wang BM, Li ZH, Li QX. Development of a sensitive monoclonal antibody-based enzyme-linked immunosorbent assay for the antimalaria active ingredient artemisinin in the Chinese herb L.","journal-title":"Anal Bioanal Chem"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcp.2017.03.019","volume":"139","author":"Efferth T.","year":"2017","unstructured":"Efferth T. Cancer combination therapies with artemisinin-type drugs.","journal-title":"Biochem Pharmacol"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"Longley D.B.","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies.","journal-title":"Nat Rev Cancer"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/cncr.20154","volume":"100","author":"Braun A.H.","year":"2004","unstructured":"Braun AH, Achterrath W, Wilke H, Vanhoefer U, Harstrick A, Preusser P. New systemic frontline treatment for metastatic colorectal carcinoma.","journal-title":"Cancer"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bbrc.2018.05.026","volume":"501","author":"Yao Z.","year":"2018","unstructured":"Yao Z, Bhandari A, Wang Y, Pan Y, Yang F, Chen R, Xia E, Wang O. Dihydroartemisinin potentiates antitumor activity of 5-fluorouracil against a resistant colorectal cancer cell line.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=117","first-page":"1","author":"Yang S.","year":"2018","unstructured":"Yang S, Zhang D, Shen N, Wang G, Tang Z, Chen X. Dihydroartemisinin increases gemcitabine therapeutic efficacy in ovarian cancer by inducing reactive oxygen species.","journal-title":"J Cell Biochem"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/pharmaceutics10010007","volume":"10","author":"Mannava M.K.C.","year":"2018","unstructured":"Mannava MKC, Suresh K, Kumar Bommaka M, Bhavani Konga D, Nangia A. Curcumin-artemisinin coamorphous solid: xenograft model preclinical study.","journal-title":"Pharmaceutics"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","volume":"435","author":"Oltersdorf T.","year":"2005","unstructured":"Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O\u2019Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaselli KJ, Wang B, Wendt MD, Zhang H, Fesik SW, Rosenberg SH. An inhibitor of Bcl-2 family proteins induces regression of solid tumours.","journal-title":"Nature"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1158\/1078-0432.CCR-17-1231","volume":"23","author":"Budhraja A.","year":"2017","unstructured":"Budhraja A, Turnis ME, Churchman ML, Kothari A, Yang X, Xu H, Kaminska E, Panetta JC, Finkelstein D, Mullighan CG, Opferman JT. m Modulation of navitoclax sensitivity by dihydroartemisinin-mediated MCL-1 repression in BCR-ABL(+) B-lineage acute lymphoblastic leukemia.","journal-title":"Clin Cancer Res"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/acsabm.8b00056","volume":"1","author":"Gao Z.","year":"2018","unstructured":"Gao Z, Li Y, You C, Sun K, An P, Sun C, Wang M, Zh X, Sun B. Iron Oxide Nanocarrier-mediated combination therapy of cisplatin and artemisinin for combating drug resistance through highly Increased toxic reactive oxygen species generation.","journal-title":"ACS Appl Bio Mater"},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/wjtcm.wjtcm_1_18","volume":"4","author":"Ashfaq M.K.","year":"2018","unstructured":"Ashfaq MK, AbdelBakky MS, Maqboola MT, Gula W, ElSohly MA. A preliminary study on combination therapy of artemisinin dimer oxime and topotecan against nonsmall cell lung cancer in Mice.","journal-title":"World J Tradit Chin Med"},{"key":"ref=123","first-page":"3059","volume":"15","author":"Huo L.","year":"2018","unstructured":"Huo L, Wei W, Wu S, Zhao X, Zhao C, Zhao H, Sun L. Effect of dihydroarteminin combined with siRNA targeting Notch1 on Notch1\/c-Myc signaling in T-cell lymphoma cells.","journal-title":"Exp Ther Med"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.apsb.2016.06.003","volume":"7","author":"Guo Z.","year":"2017","unstructured":"Guo Z. The modification of natural products for medical use.","journal-title":"Acta Pharm Sin B"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","volume":"47","author":"Efferth T.","year":"2008","unstructured":"Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJG, Marschall M. The antiviral activities of artemisinin and artesunate.","journal-title":"Clin Infect Dis"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00109-001-0300-8","volume":"80","author":"Efferth T.","year":"2002","unstructured":"Efferth T, Marschall M, Wang X, Huong SM, Hauber I, Olbrich A, Kronschnabl M, Stamminger T, Huang ES. Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses.","journal-title":"J Mol Med (Berl)"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/AAC.50.2.480-489.2006","volume":"50","author":"Afonso A.","year":"2006","unstructured":"Afonso A, Hunt P, Cheesman S, Alves AC, Cunha CV, do Ros\u00e1rio V, Cravo P. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca ATPase), tctp, mdr1, and cg10.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1645\/GE-3225","volume":"90","author":"Ferrer-Rodr\u00edguez I.","year":"2004","unstructured":"Ferrer-Rodr\u00edguez I, P\u00e9rez-Rosado J, Gervais GW, Peters W, Robinson BL, Serrano AE. : identification and partial characterization of an MDR1 gene in an artemisinin-resistant line.","journal-title":"J Parasitol"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2958.2007.05753.x","volume":"65","author":"Hunt P.","year":"2007","unstructured":"Hunt P, Afonso A, Creasey A, Culleton R, Sidhu ABS, Logan J, Valderramos SG, McNae I, Cheesman S, do Rosario V, Carter R, Fidock DA, Cravo P. Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites.","journal-title":"Mol Microbiol"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.exppara.2006.02.017","volume":"114","author":"Puri S.K.","year":"2006","unstructured":"Puri SK, Chandra R. : selection of a strain exhibiting stable resistance to arteether.","journal-title":"Exp Parasitol"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/AAC.44.2.344-347.2000","volume":"44","author":"Walker D.J.","year":"2000","unstructured":"Walker DJ, Pitsch JL, Peng MM, Robinson BL, Peters W, Bhisutthibhan J, Meshnick SR. Mechanisms of artemisinin resistance in the rodent malaria pathogen","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S1386-6532(06)70015-4","volume":"37","author":"Naesens L.","year":"2006","unstructured":"Naesens L, Bonnafous P, Agut H, De Clercq E. Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts.","journal-title":"J Clin Virol"},{"key":"ref=133","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/bcmd.2002.0492","volume":"28","author":"Efferth T.","year":"2002","unstructured":"Efferth T, Davey M, Olbrich A, R\u00fccker G, Gebhart E, Davey R. Activity of drugs from traditional chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.","journal-title":"Blood Cells Mol Dis"},{"key":"ref=134","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.medmal.2018.01.004","volume":"48","author":"Raffetin A.","year":"2018","unstructured":"Raffetin A, Bruneel F, Roussel C, Thellier M, Buffet P, Caumes E, Jaur\u00e9guiberry S. Use of artesunate in non-malarial indications.","journal-title":"Med Mal Infect"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.antiviral.2011.07.018","volume":"92","author":"Chou S.","year":"2011","unstructured":"Chou S, Marousek G, Auerochs S, Stamminger T, Milbradt J, Marschall M. The unique antiviral activity of artesunate is broadly effective against human cytomegaloviruses including therapy-resistant mutants.","journal-title":"Antiviral Res"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"e10370","DOI":"10.1371\/journal.pone.0010370","volume":"5","author":"Arav-Boger R.","year":"2010","unstructured":"Arav-Boger R, He R, Chiou CJ, Liu J, Woodard L, Rosenthal A, Jones-Brando L, Forman M, Posner G. Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers.","journal-title":"PLoS One"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2013.10.014","volume":"101","author":"Germi R.","year":"2014","unstructured":"Germi R, Mariette C, Alain S, Lupo J, Thiebaut A, Brion JP, Epaulard O, Saint Raymond C, Malvezzi P, Morand P. Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus.","journal-title":"Antiviral Res"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/587106","volume":"46","author":"Shapira M.Y.","year":"2008","unstructured":"Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, Caplan O, Saleh N, Efferth T, Marschall M, Wolf DG. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.","journal-title":"Clin Infect Dis"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/cid\/ciq050","volume":"52","author":"Lau P.K.H.","year":"2011","unstructured":"Lau PKH, Woods ML, Ratanjee SK, John GT. Artesunate is ineffective in controlling valganciclovir-resistant cytomegalovirus infection.","journal-title":"Clin Infect Dis"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.antiviral.2011.03.184","volume":"90","author":"Wolf D.G.","year":"2011","unstructured":"Wolf DG, Shimoni A, Resnick IB, Stamminger T, Neumann AU, Chou S, Efferth T, Caplan O, Rose J, Nagler A, Marschall M. Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.","journal-title":"Antiviral Res"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4269\/ajtmh.2002.66.130","volume":"66","author":"Batty K.T.","year":"2002","unstructured":"Batty KT, Iletr KE, Powell SM, Martin J, Davis TME. Relative bioavailability of artesunate and dihydroartemisinin: Investigations in the isolated perfused rat liver and in healthy Caucasian volunteers.","journal-title":"Am J Trop Med Hyg"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcv.2013.02.005","volume":"57","author":"Hakacova N.","year":"2013","unstructured":"Hakacova N, Klingel K, Kandolf R, Engdahl E, Fogdell-Hahn A, Higgins T. First therapeutic use of Artesunate in treatment of human herpesvirus 6B myocarditis in a child.","journal-title":"J Clin Virol"},{"key":"ref=143","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/molecules22020303","volume":"22","author":"Jana S.","year":"2017","unstructured":"Jana S, Iram S, Thomas J, Hayat MQ, Pannecouque C, Dehaen W. Application of the triazolization reaction to afford dihydroartemisinin derivatives with anti-HIV activity.","journal-title":"Molecules"},{"key":"ref=144","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1128\/JVI.78.20.11219-11232.2004","volume":"78","author":"Sanchez V.","year":"2004","unstructured":"Sanchez V, McElroy AK, Yen J, Tamrakar S, Clark CL, Schwartz RA, Spector DH. Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production.","journal-title":"J Virol"},{"key":"ref=145","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00018-010-0510-8","volume":"68","author":"Michaelis M.","year":"2011","unstructured":"Michaelis M, Paulus C, L\u00f6schmann N, Dauth S, Stange E, Doerr HW, Nevels M, Cinatl J. The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication.","journal-title":"Cell Mol Life Sci"},{"key":"ref=146","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm1777","volume":"14","author":"Shen L.","year":"2008","unstructured":"Shen L, Peterson S, Sedaghat AR, McMahon MA, Callender M, Zhang H, Zhou Y, Pitt E, Anderson KS, Acosta EP, Siliciano RF. Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs.","journal-title":"Nat Med"},{"key":"ref=147","doi-asserted-by":"crossref","first-page":"24334","DOI":"10.1371\/journal.pone.0024334","volume":"6","author":"He R.","year":"2011","unstructured":"He R, Mott BT, Rosenthal AS, Genna DT, Posner GH, Arav-Boger R. An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-aancer activities.","journal-title":"PLoS One"},{"key":"ref=148","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bcp.2008.10.015","volume":"77","author":"Hartwig C.L.","year":"2009","unstructured":"Hartwig CL, Rosenthal AS, D\u2019Angelo J, Griffin CE, Posner GH, Cooper RA. Accumulation of artemisinin trioxane derivatives within neutral lipids of malaria parasites is endoperoxide-dependent.","journal-title":"Biochem Pharmacol"},{"key":"ref=149","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1002\/chem.201800729","volume":"24","author":"Fr\u00f6hlich T.","year":"2018","unstructured":"Fr\u00f6hlich T, Hahn F, Belmudes L, Leidenberger M, Friedrich O, Kappes B, Cout\u00e9 Y, Marschall M, Tsogoeva SB. Synthesis of artemisinin-derived dimers, trimers and dendrimers: investigation of their antimalarial and antiviral activities including putative mechanisms of action.","journal-title":"Chemistry"},{"key":"ref=150","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2005.10.003","volume":"69","author":"Kaptein S.J.F.","year":"2006","unstructured":"Kaptein SJF, Efferth T, Leis M, Rechter S, Auerochs S, Kalmer M, Bruggeman CA, Vink C, Stamminger T, Marschall M. The anti-malaria drug artesunate inhibits replication of cytomegalovirus and","journal-title":"Antiviral Res"},{"key":"ref=151","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/AAC.01972-13","volume":"58","author":"Cai H.","year":"2014","unstructured":"Cai H, Kapoor A, He R, Venkatadri R, Forman M, Posner GH, Arav-Boger R. combination of anti-cytomegalovirus compounds acting through different targets: Role of the slope parameter and insights into mechanisms of action.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=152","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.placenta.2014.11.003","volume":"36","author":"Mor\u00e8re L.","year":"2015","unstructured":"Mor\u00e8re L, Andouard D, Labrousse F, Saade F, Calliste CA, Cotin S, Aubard Y, Rawlinson WD, Esclaire F, Hantz S, Ploy MC, Alain S. model of congenital cytomegalovirus infection and new combination therapies.","journal-title":"Placenta"},{"key":"ref=153","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3851\/IMP3028","volume":"21","author":"Drouot E.","year":"2016","unstructured":"Drouot E, Piret J, Boivin G. Artesunate demonstrates synergism with several antiviral agents against human cytomegalovirus.","journal-title":"Antivir Ther (Lond)"},{"key":"ref=154","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1128\/AAC.00519-12","volume":"56","author":"He R.","year":"2012","unstructured":"He R, Park K, Cai H, Kapoor A, Forman M, Mott B, Posner GH, Arav-Boger R. Artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=155","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.antiviral.2011.07.018","volume":"92","author":"Chou S.","year":"2011","unstructured":"Chou S, Marousek G, Auerochs S, Stamminger T, Milbradt J, Marschall M. The unique antiviral activity of artesunate is broadly effective against human cytomegaloviruses including therapy-resistant mutants.","journal-title":"Antiviral Res"},{"key":"ref=156","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.antiviral.2015.09.007","volume":"123","author":"Canivet C.","year":"2015","unstructured":"Canivet C, Menasria R, Rh\u00e9aume C, Piret J, Boivin G. Valacyclovir combined with artesunate or rapamycin improves the outcome of herpes simplex virus encephalitis in mice compared to antiviral therapy alone.","journal-title":"Antiviral Res"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T04:27:40Z","timestamp":1694579260000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169244\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":156,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,28]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026619666190122144217","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,28]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}